Application of rhEGF (recombinant human Epidermal Growth Factor) in preparation of medicament for preventing and treating cerebral ischemia
A technology for cerebral ischemia and focal cerebral ischemia, which can be used in application, food preparation, drug combination, etc., and can solve problems such as poor curative effect
Inactive Publication Date: 2015-05-27
TIANJIN GOALGEN BIOTECH
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0007] Many neuroprotective agents theoretical
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Login to View More
PUM
Login to View More
Abstract
The invention discloses an application of rhEGF (recombinant human Epidermal Growth Factor) in preparation of a medicament or health product for preventing and treating cerebral ischemia. A pharmacological research shows that the rhEGF has a certain treatment effect on acute/chronic ischemic cerebrovascular diseases, and the medicament can pass through a blood brain barrier, is mainly distributed at a cerebral hemisphere, a brain stem and the like, has an effect of relieving spasm of vascular smooth muscles, and can expand small blood vessels, reduce cerebral vascular resistance, increase the cerebral blood flow, protect endothelial cells and improve microcirculation. The medicament can increase cerebral perfusion of a distant part after MCAO (middle cerebral artery occlusion), resist cell apoptosis, protect neurons of the distant part, and reduce lost contact damages, caused by interruption of a nerve fiber conduction path, to brain tissues of the distant part. Therefore, the medicament can play a certain part in clinical prognosis after improvement of apoplexy by reducing brain dysfunctions of the distant part.
Description
technical field [0001] The invention relates to the use of rhEGF in preventing and treating cerebrovascular diseases, in particular to the use of rhEGF in the preparation of medicines for preventing and treating cerebral ischemia. Background technique [0002] Cerebrovascular disease is one of the major diseases that seriously endanger human life and health in the world today. [0003] common diseases and frequently-occurring diseases. Cerebral ischemia is a kind of cerebrovascular accident, and it is a common disease in middle-aged and elderly people. [0004] Diseases are a serious threat to human health and life. In recent years, with the continuous development of science and technology, research on [0005] Scholars' in-depth research on the pathogenesis of cerebral ischemia and the cascade reaction of brain tissue cell damage found that the [0006] Inhibition of apoptosis, reduction of inflammatory response and free radicals and other ways to relieve brain tissue d...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K38/18A23L1/29A61P9/10A23L33/00
Inventor 梁青梁兰邹庆薇郝瑞雪闻家兴王菁于琪顾久莹田雪李姣刘建强
Owner TIANJIN GOALGEN BIOTECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com